Trademarkia Logo

Australia

AU$
c-srRNA
Registered: Registered/protected

Last updated on 31 Oct 2022

Owner Info

Elixirgen Therapeutics, Inc.

855 N. Wolfe St. Suite 624

Baltimore, MD, 21205 UNITED STATES OF AMERICA,

Serial Number

2232614 filed on 1 Dec 2021

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

c-srRNA

Classification Information


Class [005]
Dosage medium to give a drug and creature preparation; Vaccines.

Class [044]
Gene therapy, Cell therapy, Regenerative medicine.

Mark Details


Serial Number

2232614

Registered On

1 Dec 2021

Renewal On

1 Dec 2031

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
31st Oct 2022IP Right Registered correspondence sent
31st Oct 2022IP Right Registration Published
31st Oct 2022Status change to Registered/Protected
22nd Aug 2022Application Accepted correspondence sent
22nd Aug 2022IP Right has been Examined
22nd Aug 2022IP Right Acceptance Published
22nd Aug 2022Status change to Accepted
21st Jul 2022Examination Response Received
16th Feb 2022Adverse Report (Examination) correspondence sent
16th Feb 2022IP Right has been Examined